Evidence map›Paper›PMID 37373266›Full record

ArticleInternational journal of molecular sciences2023

Molecular

Anelis Maria Marin, Denise Kusma Wosniaki, Heloisa Bruna Soligo Sanchuki, Eduardo Cilião Munhoz, Jeanine Marie Nardin, Gabriela Silva Soares, Dhienifer Caroline Espinace, João Samuel de Holanda Farias, Bruna Veroneze, Luiz Felipe Becker and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Divergent gene expression ofFrontiers in oncology · 2025
    Article
  4. Article
  5. Expression ofFrontiers in oncology · 2024
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Anelis Maria MarinLaboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Denise Kusma WosniakiLaboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Heloisa Bruna Soligo SanchukiLaboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Eduardo Cilião MunhozErasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Jeanine Marie NardinErasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Gabriela Silva SoaresLaboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
Dhienifer Caroline EspinaceLaboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.
João Samuel de Holanda FariasErasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Bruna VeronezeErasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Luiz Felipe BeckerErasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Guilherme Lima CostaErasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Olair Carlos BeltrameErasto Gaertner Hospital, Curitiba 81520-060, Brazil.
Jaqueline Carvalho de OliveiraDepartment of Genetics, Federal University of Parana, Curitiba 81531-980, Brazil.ORCID 0000-0002-5314-3107
Geison CambriInstituto de Biologia Molecular do Paraná (IBMP), Curitiba 81350-010, Brazil.
Dalila Luciola ZanetteLaboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.ORCID 0000-0001-9397-4127
Mateus Nóbrega AokiLaboratory for Applied Science and Technology in Health, Carlos Chagas Institute, Oswaldo Cruz Foundation (Fiocruz), Curitiba 81350-010, Brazil.ORCID 0000-0001-5166-2897
Fundação Carlos Chagas · BRHospital Erasto Gaertner · BRInstituto de Biologia Molecular do Paraná · BRUniversidade Federal do Paraná · BR

Funding

National Council for Scientific and Technological Development 445940/2020-4Oswaldo Cruz Foundation VPPCB-007-FIO-18-2-113Oswaldo Cruz Foundation VPPIS-004-FIO-18-58
6 · The paper itself

Abstract

Chronic myeloid leukemia (CML) is a well-characterized oncological disease in which virtually all patients possess a translocation (9;22) that generates the tyrosine kinase

Indexed as

Fusion Proteins, bcr-ablLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBrazilDrug Resistance, NeoplasmHumansMutationProtein Kinase InhibitorsTranslocation, GeneticFusion Proteins, bcr-ablProtein Kinase InhibitorsABL1 mutationBCR::ABL1chronic myeloid leukemiaprognosticTKI

Identifiers

PMID37373266
PMCPMC10299107
OpenAlexW4380680738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.